INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2009

Vitamin E maintained cognition in Alzheimer's patients who showed reduced oxidative stress, but was linked to worse cognitive decline in non-respondents.

Fifty-seven Alzheimer's disease patients were randomized to receive placebo or 800 IU of vitamin E daily for six months, with 33 finishing the trial. Among vitamin E-treated patients, respondents showed lower blood oxidized glutathione (GSSG) levels and maintained cognitive test scores. In non-respondents where oxidative stress was not prevented, cognition decreased sharply to levels lower than those taking placebo.

Study type
Randomized controlled trial
Who was studied
57 Alzheimer's disease patients recruited, 33 completed
What was measured
Blood oxidized glutathione (GSSG) and cognitive test scores (MMSE, Blessed-Dementia Scale, Clock Drawing Test)

THE PAPER

Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.

Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J. J Alzheimers Dis, 2009.

PubMed 19494439 ↗DOI 10.3233/jad-2009-1033 ↗

Nutrients & adequacyBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.